Abortion pills are safe and effective, widely accessible online and easy to use.
The abortion pill mifepristone used in combination with another medication—misoprostol—can safely and effectively end a pregnancy. Mifepristone interrupts the flow of the hormone progesterone that sustains a pregnancy and misoprostol causes contractions to expel the contents of the uterus. mifepristone, known as RU-486, in 1980. Chemist Georges Teutsch first synthesized mifepristone and endocrinologist Étienne-Émile Baulieu arranged tests of its use for medical abortion.
The same year, anti-abortion protests in France caused Rousel-Uclaf’s owner Hoechst AG of Germany to stop distributing mifepristone. The French government responded by ordering Roussel-Uclaf to resume selling the medication in the interest of public health. at the time, “I could not permit the abortion debate to deprive women of a product that represents medical progress.
including the U.S. National Right to Life Committee, Roussel-Uclaf and Hoechst AG declined to bring the drug to the U.S. market for fear of boycotts and lost profits. Instead, the company donated all rights for medical uses of mifepristone in the U.S. to the Population Council—a nonprofit that conducts international research on reproductive health.
The Population Council then tried to find a large drug company willing to develop the drug for the U.S. market. After threatened boycotts from anti-abortion groups, large drug companies refused, so in 1995, the Population Council
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Johnson & Johnson asks FDA to authorize Covid-19 vaccine booster shotsJohnson & Johnson has asked the FDA to authorize booster shots for its coronavirus vaccine, but has left it up to the FDA and the US Centers for Disease Control and Prevention to decide just who should get their boosters and when.
Read more »
Johnson & Johnson seeks FDA authorization of Covid booster shotJ&J said Monday that giving a second dose two months after the first increased protection against symptomatic moderate to severe Covid-19 to 94 percent, with 100 percent protection against severe illness.
Read more »
Johnson & Johnson Submits Booster Shot Data To FDA For ApprovalThe company has released data suggesting the second shot offers strong protection against Covid-19.
Read more »
Johnson & Johnson Asks FDA to Authorize Covid-19 BoosterJohnson & Johnson has asked U.S. health regulators to authorize a booster dose for its Covid-19 vaccine, citing studies showing it improved protection among adults who previously received a single shot
Read more »
Johnson & Johnson Requests FDA Approval for Vaccine Booster DosesJohnson & Johnson asked the FDA on Tuesday to authorize an extra dose of its COVID-19 vaccine as a booster shot.
Read more »
AstraZeneca asks FDA to authorize Covid antibody treatment to prevent illnessIf authorized, it would be the first long-acting drug for people with compromised immune systems who don't get sufficient protection from vaccination.
Read more »